By adapting a tool so it can analyze antibodies from those who’ve had COVID-19, HMS researchers hope to determine true infection rates, disease lethality and vaccine design.

At the request of the state, graduating HMS students are being given an early degree option so they may help serve in the COVID-19 fight.

At local hospitals, new clinical trials are currently underway to evaluate an antiviral drug as a possible treatment for COVID-19.

This year’s HMS Match Day ceremony reflected joy and purpose for MD grads as the ritual went virtual for the first time.